-
DYNAMIC POPULATION MODELING FOR TOBACCO HARM REDUCTION - A TIME-SERIES APPROACH
Mar 18, 2026, 21:38 PM -
REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY
Mar 18, 2026, 21:38 PM -
REAL-WORLD OUTCOMES OF MECHANICAL, PORCINE, AND DURABLE VALVES IN SEVERE AORTIC STENOSIS: SURVIVAL, REINTERVENTION, AND EARLY MORTALITY ANALYSIS
Mar 18, 2026, 21:38 PM -
PROBABILISTIC LINKING OF CLAIMS AND ELECTRONIC HEALTH RECORD (EHR) ENCOUNTERS USING THE FELLEGI-SUNTER STATISTICAL FRAMEWORK
Mar 18, 2026, 21:38 PM -
EXPLORING PREFERENCES FOR LYME DISEASE VACCINES IN THE UNITED STATES: A LATENT CLASS APPROACH
Mar 18, 2026, 21:38 PM -
INCLUSION OF PATIENT-REPORTED OUTCOME MEASURES FOR PEDIATRIC VERSUS ADULT POPULATIONS IN FDA BIOLOGICAL AND NOVEL DRUG THERAPY APPROVALS FROM 2021-2025
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING TO DIFFERENTIATE CONGESTIVE HEART FAILURE ONSET AMONG HIGH-RISK PATIENTS IDENTIFIED BY THE FRAMINGHAM RISK SCORE
Mar 18, 2026, 21:38 PM -
QUANTIFYING THE OPPORTUNITY: THE ECONOMIC AND COMMERCIAL CASE FOR ALS TREATMENT INNOVATION
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
PRESERVING VISION AND PRODUCTIVITY: THE SOCIAL IMPACT OF INNOVATIVE DME THERAPY IN CHILE
Mar 18, 2026, 21:38 PM -
TITLE: COST-UTILITY ANALYSIS OF CALCITONIN GENE-RELATED PEPTIDE ANTIBODIES FOR PATIENTS WITH CHRONIC MIGRAINE: A UNITED STATES PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
INCREASED RISK OF DIABETIC KETOACIDOSIS IN ADULTS WITH DELAYED DIAGNOSIS OF TYPE 1 DIABETES
Mar 18, 2026, 21:38 PM -
REAL-WORLD PERIOPERATIVE IMMUNOTHERAPY AND CELLULAR THERAPY IN OLDER ADULTS WITH SOLID TUMORS: A 2021-2025 MEDICARE-EMR LINKED ANALYSIS
Mar 18, 2026, 21:38 PM -
UTILIZATION, EXPENDITURE, AND PRICE TRENDS FOR EZETIMIBE AND NOVEL LIPID-LOWERING MEDICATIONS IN U.S. MEDICAID DRUG UTILIZATION DATA, 2002-2024
Mar 18, 2026, 21:38 PM -
PATTERNS AND PREDICTORS OF ANTIDEPRESSANT USE AMONG ADULTS WITH DEPRESSION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
EVOLVING COST-EFFECTIVENESS THRESHOLDS AT NICE: CHANGES IN THE BASE THRESHOLD AND USE OF HIGHER THRESHOLDS IN SPECIAL CASES
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN AND COST EFFECTIVENESS OF ADVANCED GALLBLADDER CANCER TREATMENT IN NORTHEAST INDIA: A DUAL PHASE ASSESSMENT
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF DIAGNOSED METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN US ADULTS WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
EXPLORING THE OPTIMAL SHARE OF PHARMACEUTICAL VALUE FOR INDUSTRY AND SOCIETY: AN APPLICATION TO THE US CONTEXT
Mar 18, 2026, 21:38 PM -
ACCOUNTING FOR DIFFERENCES IN MAINTENANCE STUDY DESIGNS: METHODOLOGICAL CONSIDERATIONS FOR NMA
Mar 18, 2026, 21:38 PM
